ARCHIVES

ACCC 10th Anniversary Meeting Zeroes in On Impact Of DRGs

This article is from The Cancer Letter archive.

Vol. 10 No. 08 | February 24, 1984

Download PDF Visit The Full Archive

Related Articles

NCI To Implement Recommendations, Sondik Says

September 2, 1988

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

Letter: A Modest Proposal To Abolish FDA

January 26, 1996

How Cancer Control Grants, Contracts Distributed By States

October 13, 1978